Skip to main content
Top
Published in: American Journal of Clinical Dermatology 2/2003

01-02-2003 | Review Article

Ichthyosis

Etiology, Diagnosis, and Management

Authors: Dr John J. DiGiovanna, Leslie Robinson-Bostom

Published in: American Journal of Clinical Dermatology | Issue 2/2003

Login to get access

Abstract

The ichthyoses are a heterogeneous group of disorders with both inherited and acquired forms. Clinical presentation, pattern of inheritance, and laboratory evaluation may establish a precise diagnosis, which can assist in prognosis and genetic counseling.
Congenital autosomal recessive ichthyosis (CARI) usually presents at birth, often as a collodion baby. CARI can progress into any one of a spectrum of disorders. Lamellar ichthyosis is characterized by dark, plate (armor)-like scale. This disease is often caused by mutations in the gene encoding the enzyme transglutaminase 1. Congenital ichthyosiform erythroderma is another phenotype within CARI, marked by generalized redness and fine white scale.
Epidermolytic hyperkeratosis is an autosomal dominant disorder characterized by hyperkeratosis and blistering, and at least six clinical phenotypes have been described. It may be due to mutations in the gene encoding the intermediate filament proteins keratin 1 and 10.
Ichthyosis vulgaris is the most common ichthyosis, and is inherited in an autosomal dominant pattern. Involvement is generally mild and may vary greatly with climate and humidity. X-linked ichthyosis, due to a defect in the enzyme steroid sulfatase, affects males with generalized scaling that usually begins soon after birth. There may be associated corneal opacities that do not affect vision.
Sjögren-Larsson syndrome is an autosomal recessive ichthyosis associated with progressive spastic paralysis and mental retardation. This condition is caused by mutations in the gene for fatty aldehyde dehydrogenase. Refsum’s disease, due to accumulation of phytanic acid, results in ichthyosis and progressive neurologic dysfunction.
The erythrokeratodermas are characterized by hyperkeratosis and localized erythema. Erythrokeratodermia variabilis is autosomal dominant and characterized by generalized or localized hyperkeratosis and migratory red patches. Mutations in the genes encoding the gap junction proteins, connexins, underlie this disorder.
Netherton’s syndrome is an autosomal recessive disorder characterized by ichthyosis, a hair shaft abnormality and atopy. The ichthyosis may present at birth with erythroderma or in some cases a collodion presentation. However, a frequent characteristic skin manifestation is ichthyosis linearis circumflexa. Netherton’s syndrome has been found to be due to an abnormality in a serum protease inhibitor. Acquired ichthyosis can have a variety of underlying causes including neoplastic, infectious, drugs, endocrine, metabolic, autoimmune, malabsorptive states, and hereditary. Topical, and in more severe cases, systemic, therapy are useful in managing this array of disorders of cornification.
Footnotes
1
Use of tradenames is for product identification only and does not imply endorsement.
 
Literature
1.
go back to reference Williams ML, Elias PM. Genetically transmitted, generalized disorders of cornification: the ichthyoses. Dermatol Clin 1987; 5 (1): 155–178PubMedCrossRef Williams ML, Elias PM. Genetically transmitted, generalized disorders of cornification: the ichthyoses. Dermatol Clin 1987; 5 (1): 155–178PubMedCrossRef
2.
go back to reference Williams ML, Elias PM. From basket weave to barrier: unifying concepts for the pathogenesis of the disorders of cornification [editorial]. Arch Dermatol 1993; 129 (5): 626–629PubMedCrossRef Williams ML, Elias PM. From basket weave to barrier: unifying concepts for the pathogenesis of the disorders of cornification [editorial]. Arch Dermatol 1993; 129 (5): 626–629PubMedCrossRef
3.
go back to reference DiGiovanna JJ. Ichthyosiform dermatoses. In: Freedberg IM, Eisen AZ, Wolff K, et al., editors. Fitzpatrick’s dermatology in general medicine. New York: McGraw-Hill, 1999: 581–603 DiGiovanna JJ. Ichthyosiform dermatoses. In: Freedberg IM, Eisen AZ, Wolff K, et al., editors. Fitzpatrick’s dermatology in general medicine. New York: McGraw-Hill, 1999: 581–603
4.
go back to reference Williams ML, Elias PM. Heterogeneity in autosomal recessive ichthyosis: clinical and biochemical differentiation of lamellar ichthyosis and nonbullous congenital ichthyosiform erythroderma. Arch Dermatol 1985; 121 (4): 477–488PubMedCrossRef Williams ML, Elias PM. Heterogeneity in autosomal recessive ichthyosis: clinical and biochemical differentiation of lamellar ichthyosis and nonbullous congenital ichthyosiform erythroderma. Arch Dermatol 1985; 121 (4): 477–488PubMedCrossRef
5.
go back to reference Hazell M, Marks R. Clinical, histologic, and cell kinetic discriminants between lamellar ichthyosis and nonbullous congenital ichthyosiform erythroderma. Arch Dermatol 1985; 121 (4): 489–493PubMedCrossRef Hazell M, Marks R. Clinical, histologic, and cell kinetic discriminants between lamellar ichthyosis and nonbullous congenital ichthyosiform erythroderma. Arch Dermatol 1985; 121 (4): 489–493PubMedCrossRef
6.
go back to reference Laiho E, Ignatius J, Mikkola H, et al. Transglutaminase 1 mutations in autosomal recessive congenital ichthyosis: private and recurrent mutations in an isolated population. Am J Hum Genet 1997; 61 (3): 529–538PubMedCrossRef Laiho E, Ignatius J, Mikkola H, et al. Transglutaminase 1 mutations in autosomal recessive congenital ichthyosis: private and recurrent mutations in an isolated population. Am J Hum Genet 1997; 61 (3): 529–538PubMedCrossRef
7.
go back to reference Bale SJ, Russell LJ, Lee ML, et al. Congenital recessive ichthyosis unlinked to loci for epidermal transglutaminases. J Invest Dermatol 1996; 107 (6): 808–811PubMedCrossRef Bale SJ, Russell LJ, Lee ML, et al. Congenital recessive ichthyosis unlinked to loci for epidermal transglutaminases. J Invest Dermatol 1996; 107 (6): 808–811PubMedCrossRef
8.
go back to reference Fischer J, Faure A, Bouadjar B, et al. Two new loci for autosomal recessive ichthyosis on chromosomes 3p21 and 19p12-q12 and evidence for further genetic heterogeneity. Am J Hum Genet 2000 Mar; 66 (3): 904–913PubMedCrossRef Fischer J, Faure A, Bouadjar B, et al. Two new loci for autosomal recessive ichthyosis on chromosomes 3p21 and 19p12-q12 and evidence for further genetic heterogeneity. Am J Hum Genet 2000 Mar; 66 (3): 904–913PubMedCrossRef
9.
go back to reference Virolainen E, Wessman M, Hovatta I, et al. Assignment of a novel locus for autosomal recessive congenital ichthyosis to chromosome 19p13.1-p13.2. Am J Hum Genet 2000; 66 (3): 1132–1137PubMedCrossRef Virolainen E, Wessman M, Hovatta I, et al. Assignment of a novel locus for autosomal recessive congenital ichthyosis to chromosome 19p13.1-p13.2. Am J Hum Genet 2000; 66 (3): 1132–1137PubMedCrossRef
10.
go back to reference Frenk E, de Techtermann F. Self-healing collodion baby: evidence for autosomal recessive inheritance. Pediatr Dermatol 1992; 9 (2): 95–97PubMedCrossRef Frenk E, de Techtermann F. Self-healing collodion baby: evidence for autosomal recessive inheritance. Pediatr Dermatol 1992; 9 (2): 95–97PubMedCrossRef
11.
go back to reference DiGiovanna JJ, Bale SJ. Clinical heterogeneity in epidermolytic hyperkeratosis. Arch Dermatol 1994; 130 (8): 1026–1035PubMedCrossRef DiGiovanna JJ, Bale SJ. Clinical heterogeneity in epidermolytic hyperkeratosis. Arch Dermatol 1994; 130 (8): 1026–1035PubMedCrossRef
12.
go back to reference DiGiovanna JJ, Bale SJ. Epidermolytic hyperkeratosis: applied molecular genetics. J Invest Dermatol 1994; 102 (3): 390–394PubMedCrossRef DiGiovanna JJ, Bale SJ. Epidermolytic hyperkeratosis: applied molecular genetics. J Invest Dermatol 1994; 102 (3): 390–394PubMedCrossRef
13.
go back to reference Rothnagel JA, Traupe H, Wojcik S, et al. Mutations in the rod domain of keratin 2e in patients with ichthyosis bullosa of Siemens. Nat Genet 1994; 7 (4): 485–490PubMedCrossRef Rothnagel JA, Traupe H, Wojcik S, et al. Mutations in the rod domain of keratin 2e in patients with ichthyosis bullosa of Siemens. Nat Genet 1994; 7 (4): 485–490PubMedCrossRef
14.
go back to reference Wells RS, Kerr CB. Clinical features of autosomal dominant and sex-linked ichthyosis in an English population. BMJ 1966; 1: 947–950PubMedCrossRef Wells RS, Kerr CB. Clinical features of autosomal dominant and sex-linked ichthyosis in an English population. BMJ 1966; 1: 947–950PubMedCrossRef
15.
go back to reference Anton-Lamprecht I, Hofbauer M. Ultrastructural distinctive features of autosomal dominant ichthyosis vulgaris and X-linked recessive ichthyosis. Dermatologica 1972; 145 (1): 60–64PubMedCrossRef Anton-Lamprecht I, Hofbauer M. Ultrastructural distinctive features of autosomal dominant ichthyosis vulgaris and X-linked recessive ichthyosis. Dermatologica 1972; 145 (1): 60–64PubMedCrossRef
16.
go back to reference Sybert VP, Dale BA, Holbrook KA. Ichthyosis vulgaris: identification of a defect in synthesis of filaggrin correlated with an absence of keratohyaline granules. J Invest Dermatol 1985; 84 (3): 191–194PubMedCrossRef Sybert VP, Dale BA, Holbrook KA. Ichthyosis vulgaris: identification of a defect in synthesis of filaggrin correlated with an absence of keratohyaline granules. J Invest Dermatol 1985; 84 (3): 191–194PubMedCrossRef
17.
go back to reference Nirunsuksiri W, Presland RB, Brumbaugh SG, et al. Decreased profilaggrin expression in ichthyosis vulgaris is a result of selectively impaired posttranscriptional control. J Biol Chem 1995; 270 (2): 871–876PubMedCrossRef Nirunsuksiri W, Presland RB, Brumbaugh SG, et al. Decreased profilaggrin expression in ichthyosis vulgaris is a result of selectively impaired posttranscriptional control. J Biol Chem 1995; 270 (2): 871–876PubMedCrossRef
18.
go back to reference Richard G, Lin JP, Smith L, et al. Linkage studies in erythrokeratodermias: fine mapping, genetic heterogeneity and analysis of candidate genes. J Invest Dermatol 1997; 109 (5): 666–671PubMedCrossRef Richard G, Lin JP, Smith L, et al. Linkage studies in erythrokeratodermias: fine mapping, genetic heterogeneity and analysis of candidate genes. J Invest Dermatol 1997; 109 (5): 666–671PubMedCrossRef
19.
go back to reference Richard G, Smith LE, Bailey RA, et al. Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis. Nat Genet 1998; 20 (4): 366–369PubMedCrossRef Richard G, Smith LE, Bailey RA, et al. Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis. Nat Genet 1998; 20 (4): 366–369PubMedCrossRef
20.
go back to reference Rizzo WB, Craft DA. Sjogren-Larsson syndrome, deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol: NAD+ oxidoreductase in cultured fibroblasts. J Clin Invest 1991; 88 (5): 1643–1648PubMedCrossRef Rizzo WB, Craft DA. Sjogren-Larsson syndrome, deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol: NAD+ oxidoreductase in cultured fibroblasts. J Clin Invest 1991; 88 (5): 1643–1648PubMedCrossRef
21.
go back to reference Rizzo WB, Carney G, Lin Z. The molecular basis of Sjogren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene. Am J Hum Genet 1999; 65 (6): 1547–1560PubMedCrossRef Rizzo WB, Carney G, Lin Z. The molecular basis of Sjogren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene. Am J Hum Genet 1999; 65 (6): 1547–1560PubMedCrossRef
22.
go back to reference De Laurenzi V, Rogers GR, Hamrock DJ, et al. Sjogren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene. Nat Genet 1996; 12 (1): 52–57PubMedCrossRef De Laurenzi V, Rogers GR, Hamrock DJ, et al. Sjogren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene. Nat Genet 1996; 12 (1): 52–57PubMedCrossRef
23.
go back to reference Rizzo WB, Craft DA, Kelson TL, et al. Prenatal diagnosis of Sjogren-Larsson syndrome using enzymatic methods. Prenat Diagn 1994; 14 (7): 577–581PubMedCrossRef Rizzo WB, Craft DA, Kelson TL, et al. Prenatal diagnosis of Sjogren-Larsson syndrome using enzymatic methods. Prenat Diagn 1994; 14 (7): 577–581PubMedCrossRef
24.
go back to reference Chavanas S, Bodemer C, Rochat A, et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 2000 Jun; 25 (2): 141–142PubMedCrossRef Chavanas S, Bodemer C, Rochat A, et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 2000 Jun; 25 (2): 141–142PubMedCrossRef
25.
26.
go back to reference Kitareewan S, Burka LT, Tomer KB, et al. Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR. Mol Biol Cell 1996; 7 (8): 1153–1166PubMed Kitareewan S, Burka LT, Tomer KB, et al. Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR. Mol Biol Cell 1996; 7 (8): 1153–1166PubMed
27.
go back to reference Itin PH, Sarasin A, Pittelkow MR. Trichothiodystrophy: update on the sulfur-deficient brittle hair syndromes. J Am Acad Dermatol 2001; 44 (6): 891–920PubMedCrossRef Itin PH, Sarasin A, Pittelkow MR. Trichothiodystrophy: update on the sulfur-deficient brittle hair syndromes. J Am Acad Dermatol 2001; 44 (6): 891–920PubMedCrossRef
28.
go back to reference Takayama K, Salazar EP, Broughton BC, et al. Defects in the DNA repair and transcription gene ERCC2 (XPD) in trichothiodystrophy. Am J Hum Genet 1996; 58 (2): 263–270PubMed Takayama K, Salazar EP, Broughton BC, et al. Defects in the DNA repair and transcription gene ERCC2 (XPD) in trichothiodystrophy. Am J Hum Genet 1996; 58 (2): 263–270PubMed
29.
go back to reference Weeda G, Eveno E, Donker I, et al. A mutation in the XPB/ERCC3 DNA repair transcription gene, associated with trichothiodystrophy. Am J Hum Genet 1997; 60 (2): 320–329PubMed Weeda G, Eveno E, Donker I, et al. A mutation in the XPB/ERCC3 DNA repair transcription gene, associated with trichothiodystrophy. Am J Hum Genet 1997; 60 (2): 320–329PubMed
30.
go back to reference Stefanini M, Vermeulen W, Weeda G, et al. A new nucleotide-excision-repair gene associated with the disorder trichothiodystrophy. Am J Hum Genet 1993; 53 (4): 817–821PubMed Stefanini M, Vermeulen W, Weeda G, et al. A new nucleotide-excision-repair gene associated with the disorder trichothiodystrophy. Am J Hum Genet 1993; 53 (4): 817–821PubMed
31.
go back to reference Griffiths WAD, Judge MR, Leigh IM. Disorders of keratinization. In: Champion RH, Burton JL, Burns DA, et al., editors. Rook/Wilkinson/Ebling textbook of dermatology. Oxford: Blackwell Science, 1998: 1483–1530 Griffiths WAD, Judge MR, Leigh IM. Disorders of keratinization. In: Champion RH, Burton JL, Burns DA, et al., editors. Rook/Wilkinson/Ebling textbook of dermatology. Oxford: Blackwell Science, 1998: 1483–1530
32.
go back to reference Sneddon IB. Acquired ichthyosis in Hodgkin’s disease. Br J Dermatol 1955; 1: 763–764 Sneddon IB. Acquired ichthyosis in Hodgkin’s disease. Br J Dermatol 1955; 1: 763–764
33.
go back to reference Lucker GP, Steijlen PM. Acrokeratosis paraneoplastica (Bazex syndrome) occurring with acquired ichthyosis in Hodgkin’ disease. Br J Dermatol 1995; 133 (2): 322–325PubMedCrossRef Lucker GP, Steijlen PM. Acrokeratosis paraneoplastica (Bazex syndrome) occurring with acquired ichthyosis in Hodgkin’ disease. Br J Dermatol 1995; 133 (2): 322–325PubMedCrossRef
34.
go back to reference Cheesbrough MJ. Acquired ichthyosis and unclassified lymphoma. Br J Dermatol 1978; 99 Suppl. 16: 26–27PubMedCrossRef Cheesbrough MJ. Acquired ichthyosis and unclassified lymphoma. Br J Dermatol 1978; 99 Suppl. 16: 26–27PubMedCrossRef
35.
go back to reference Tamura J, Shinohara M, Matsushima T, et al. Acquired ichthyosis as a manifestation of abdominal recurrence of non-Hodgkin’s lymphoma [letter]. Am J Hematol 1994; 45 (2): 191–192PubMedCrossRef Tamura J, Shinohara M, Matsushima T, et al. Acquired ichthyosis as a manifestation of abdominal recurrence of non-Hodgkin’s lymphoma [letter]. Am J Hematol 1994; 45 (2): 191–192PubMedCrossRef
36.
go back to reference Kutting B, Metze D, Luger TA, et al. Mycosis fungoides presenting as an acquired ichthyosis. J Am Acad Dermatol 1996; 34 (5 Pt 2): 887–889PubMedCrossRef Kutting B, Metze D, Luger TA, et al. Mycosis fungoides presenting as an acquired ichthyosis. J Am Acad Dermatol 1996; 34 (5 Pt 2): 887–889PubMedCrossRef
37.
go back to reference Ikada J, Oki M. Concurrent pityriasis rotunda and acquired ichthyosis with IgG myeloma. Br J Dermatol 1974; 91 (5): 585–586PubMedCrossRef Ikada J, Oki M. Concurrent pityriasis rotunda and acquired ichthyosis with IgG myeloma. Br J Dermatol 1974; 91 (5): 585–586PubMedCrossRef
39.
go back to reference Polisky RB, Bronson DM. Acquired ichthyosis in a patient with adenocarcinoma of the breast. Cutis 1986; 38 (6): 359–360PubMed Polisky RB, Bronson DM. Acquired ichthyosis in a patient with adenocarcinoma of the breast. Cutis 1986; 38 (6): 359–360PubMed
40.
go back to reference Flint GL, Flam M, Soter NA. Acquired ichthyosis: a sign of nonlymphoproliferative malignant disorders. Arch Dermatol 1975; 111 (11): 1446–1447PubMedCrossRef Flint GL, Flam M, Soter NA. Acquired ichthyosis: a sign of nonlymphoproliferative malignant disorders. Arch Dermatol 1975; 111 (11): 1446–1447PubMedCrossRef
41.
go back to reference Krakowski A, Brenner S, Covo J, et al. Acquired ichthyosis in Kaposi’s sarcoma. Dermatologica 1973; 147 (5): 348–351PubMedCrossRef Krakowski A, Brenner S, Covo J, et al. Acquired ichthyosis in Kaposi’s sarcoma. Dermatologica 1973; 147 (5): 348–351PubMedCrossRef
42.
go back to reference Bechtel MA, Callen JP. Disseminated Kaposi’s sarcoma in a patient with acquired ichthyosis. J Surg Oncol 1984; 26 (1): 22–26PubMedCrossRef Bechtel MA, Callen JP. Disseminated Kaposi’s sarcoma in a patient with acquired ichthyosis. J Surg Oncol 1984; 26 (1): 22–26PubMedCrossRef
43.
go back to reference Young L, Steinman HK. Acquired ichthyosis in a patient with acquired immunodeficiency syndrome and Kaposi’s sarcoma [letter]. J Am Acad Dermatol 1987; 16 (2 Pt 1): 395–396CrossRef Young L, Steinman HK. Acquired ichthyosis in a patient with acquired immunodeficiency syndrome and Kaposi’s sarcoma [letter]. J Am Acad Dermatol 1987; 16 (2 Pt 1): 395–396CrossRef
44.
go back to reference Grattan CE, Williams DM, Raafat F, et al. Acquired ichthyosis in a child with rhabdomyosarcoma. Pediatr Dermatol 1988; 5 (3): 167–169PubMedCrossRef Grattan CE, Williams DM, Raafat F, et al. Acquired ichthyosis in a child with rhabdomyosarcoma. Pediatr Dermatol 1988; 5 (3): 167–169PubMedCrossRef
45.
go back to reference Farrell AM, Ross JS, Thomas JM, et al. Acquired ichthyosis, alopecia and loss of hair pigment associated with leiomyosarcoma. J Eur Acad Dermatol Venereol 1998; 10 (2): 159–163PubMedCrossRef Farrell AM, Ross JS, Thomas JM, et al. Acquired ichthyosis, alopecia and loss of hair pigment associated with leiomyosarcoma. J Eur Acad Dermatol Venereol 1998; 10 (2): 159–163PubMedCrossRef
46.
go back to reference Majekodunmi AE, Femi-Pearse D. Ichthyosis: early manifestation of intestinal leiomyosarcoma. BMJ 1974; 3 (5933): 724PubMedCrossRef Majekodunmi AE, Femi-Pearse D. Ichthyosis: early manifestation of intestinal leiomyosarcoma. BMJ 1974; 3 (5933): 724PubMedCrossRef
47.
go back to reference Bergman R, Friedman-Birnbaum R, Carter A. Acquired ichthyosis in a patient with polycythemia rubra vera. Cutis 1985; 36 (2): 157–158PubMed Bergman R, Friedman-Birnbaum R, Carter A. Acquired ichthyosis in a patient with polycythemia rubra vera. Cutis 1985; 36 (2): 157–158PubMed
48.
go back to reference Kato N, Yasukawa K, Kimura K, et al. Anaplastic large-cell lymphoma associated with acquired ichthyosis. J Am Acad Dermatol 2000 May; 42 (5 Pt 2): 914–920CrossRef Kato N, Yasukawa K, Kimura K, et al. Anaplastic large-cell lymphoma associated with acquired ichthyosis. J Am Acad Dermatol 2000 May; 42 (5 Pt 2): 914–920CrossRef
49.
go back to reference Yokote R, Iwatsuki K, Hashizume H, et al. Lymphomatoid papulosis associated with acquired ichthyosis. J Am Acad Dermatol 1994; 30 (5 Pt 2): 889–892CrossRef Yokote R, Iwatsuki K, Hashizume H, et al. Lymphomatoid papulosis associated with acquired ichthyosis. J Am Acad Dermatol 1994; 30 (5 Pt 2): 889–892CrossRef
50.
51.
go back to reference Goodman DS, Teplitz ED, Wishner A, et al. Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol 1987; 17 (2 Pt 1): 210–220CrossRef Goodman DS, Teplitz ED, Wishner A, et al. Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol 1987; 17 (2 Pt 1): 210–220CrossRef
52.
go back to reference Coldiron BM, Bergstresser PR. Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus. Arch Dermatol 1989; 125 (3): 357–361PubMedCrossRef Coldiron BM, Bergstresser PR. Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus. Arch Dermatol 1989; 125 (3): 357–361PubMedCrossRef
53.
go back to reference Singh M, Kaur S, Kumar B, et al. The associated diseases with leprosy. Indian J Lepr 1987; 59 (3): 315–321PubMed Singh M, Kaur S, Kumar B, et al. The associated diseases with leprosy. Indian J Lepr 1987; 59 (3): 315–321PubMed
54.
go back to reference Kaplan MH, Sadick NS, McNutt NS, et al. Acquired ichthyosis in concomitant HIV-1 and HTLV-II infection: a new association with intravenous drug abuse. J Am Acad Dermatol 1993; 29 (5 Pt 1): 701–708CrossRef Kaplan MH, Sadick NS, McNutt NS, et al. Acquired ichthyosis in concomitant HIV-1 and HTLV-II infection: a new association with intravenous drug abuse. J Am Acad Dermatol 1993; 29 (5 Pt 1): 701–708CrossRef
55.
go back to reference Griffiths CE, Leonard JN, Walker MM. Acquired ichthyosis and sarcoidosis. Clin Exp Dermatol 1986; 11 (3): 296–298PubMedCrossRef Griffiths CE, Leonard JN, Walker MM. Acquired ichthyosis and sarcoidosis. Clin Exp Dermatol 1986; 11 (3): 296–298PubMedCrossRef
56.
go back to reference Banse-Kupin L, Pelachyk JM. Ichthyosiform sarcoidosis: report of two cases and a review of the literature. J Am Acad Dermatol 1987; 17 (4): 616–620PubMedCrossRef Banse-Kupin L, Pelachyk JM. Ichthyosiform sarcoidosis: report of two cases and a review of the literature. J Am Acad Dermatol 1987; 17 (4): 616–620PubMedCrossRef
57.
go back to reference Cather JC, Cohen PR. Ichthyosiform sarcoidosis. J Am Acad Dermatol 1999; 40 (5 Pt 2): 862–865PubMed Cather JC, Cohen PR. Ichthyosiform sarcoidosis. J Am Acad Dermatol 1999; 40 (5 Pt 2): 862–865PubMed
58.
go back to reference London RD, Lebwohl M. Acquired ichthyosis and hyperparathyroidism. J Am Acad Dermatol 1989; 21 (4 Pt 1): 801–802CrossRef London RD, Lebwohl M. Acquired ichthyosis and hyperparathyroidism. J Am Acad Dermatol 1989; 21 (4 Pt 1): 801–802CrossRef
59.
go back to reference Font J, Bosch X, Ingelmo M, et al. Acquired ichthyosis in a patient with systemic lupus erythematosus [letter]. Arch Dermatol 1990; 126 (6): 829PubMedCrossRef Font J, Bosch X, Ingelmo M, et al. Acquired ichthyosis in a patient with systemic lupus erythematosus [letter]. Arch Dermatol 1990; 126 (6): 829PubMedCrossRef
60.
go back to reference Duvic M, Jegasothy BV. Acquired ichthyosis with systemic lupus erythematosus. Arch Dermatol 1980; 116 (8): 952–954PubMedCrossRef Duvic M, Jegasothy BV. Acquired ichthyosis with systemic lupus erythematosus. Arch Dermatol 1980; 116 (8): 952–954PubMedCrossRef
61.
go back to reference Urrutia S, Vazquez F, Requena L, et al. Acquired ichthyosis associated with dermatomyositis [letter]. J Am Acad Dermatol 1987; 16 (3 Pt 1): 627–629CrossRef Urrutia S, Vazquez F, Requena L, et al. Acquired ichthyosis associated with dermatomyositis [letter]. J Am Acad Dermatol 1987; 16 (3 Pt 1): 627–629CrossRef
62.
go back to reference Roselino AM, Souza CS, Andrade JM, et al. Dermatomyositis and acquired ichthyosis as paraneoplastic manifestations of ovarian tumor. Int J Dermatol 1997; 36 (8): 611–614PubMedCrossRef Roselino AM, Souza CS, Andrade JM, et al. Dermatomyositis and acquired ichthyosis as paraneoplastic manifestations of ovarian tumor. Int J Dermatol 1997; 36 (8): 611–614PubMedCrossRef
63.
go back to reference de la Cruz-Alvarez J, Allegue F, Oliver J. Acquired ichthyosis associated with eosinophilic fasciitis. J Am Acad Dermatol 1996; 34 (6): 1079–1080PubMedCrossRef de la Cruz-Alvarez J, Allegue F, Oliver J. Acquired ichthyosis associated with eosinophilic fasciitis. J Am Acad Dermatol 1996; 34 (6): 1079–1080PubMedCrossRef
64.
go back to reference Spelman LJ, Strutton GM, Robertson IM, et al. Acquired ichthyosis in bone marrow transplant recipients. J Am Acad Dermatol 1996; 35 (1): 17–20PubMedCrossRef Spelman LJ, Strutton GM, Robertson IM, et al. Acquired ichthyosis in bone marrow transplant recipients. J Am Acad Dermatol 1996; 35 (1): 17–20PubMedCrossRef
65.
go back to reference Dilek I, Demirer T, Ustun C, et al. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia. Bone Marrow Transplant 1998; 21 (11): 1159–1161PubMedCrossRef Dilek I, Demirer T, Ustun C, et al. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia. Bone Marrow Transplant 1998; 21 (11): 1159–1161PubMedCrossRef
66.
go back to reference Parsons Jr WB. Treatment of hypercholesteremia by nicotinic acid: progress report with review of studies regarding mechanism of action. Arch Intern Med (Chicago) 1961; 107: 639–652 Parsons Jr WB. Treatment of hypercholesteremia by nicotinic acid: progress report with review of studies regarding mechanism of action. Arch Intern Med (Chicago) 1961; 107: 639–652
67.
go back to reference Winkelmann RK, Perry HO, Achor RW, et al. Cutaneous syndromes produced as side effects of triparanol therapy. Arch Derm (Chicago) 1963; 87: 372–377CrossRef Winkelmann RK, Perry HO, Achor RW, et al. Cutaneous syndromes produced as side effects of triparanol therapy. Arch Derm (Chicago) 1963; 87: 372–377CrossRef
68.
go back to reference Greist MC, Epinette WW. Cimetidine-induced xerosis and asteatotic dermatitis. Arch Dermatol 1982; 118 (4): 253–254PubMedCrossRef Greist MC, Epinette WW. Cimetidine-induced xerosis and asteatotic dermatitis. Arch Dermatol 1982; 118 (4): 253–254PubMedCrossRef
69.
go back to reference Caver CV. Clofazimine-induced ichthyosis and its treatment. Cutis 1982; 29 (4): 341–343PubMed Caver CV. Clofazimine-induced ichthyosis and its treatment. Cutis 1982; 29 (4): 341–343PubMed
70.
go back to reference Williams ML, Feingold KR, Grubauer G, et al. Ichthyosis induced by cholesterollowering drugs: implications for epidermal cholesterol homeostasis. Arch Dermatol 1987; 123 (11): 1535–1538PubMedCrossRef Williams ML, Feingold KR, Grubauer G, et al. Ichthyosis induced by cholesterollowering drugs: implications for epidermal cholesterol homeostasis. Arch Dermatol 1987; 123 (11): 1535–1538PubMedCrossRef
71.
go back to reference Niederauer HH, Bacharach-Buhles M, Altmeyer P. Ichthyosis and alopecia after maprotiline: corneolysis caused by temporary disorder of keratinization [in German]. Hautarzt 1991; 42 (7): 455–458PubMed Niederauer HH, Bacharach-Buhles M, Altmeyer P. Ichthyosis and alopecia after maprotiline: corneolysis caused by temporary disorder of keratinization [in German]. Hautarzt 1991; 42 (7): 455–458PubMed
72.
go back to reference Epstein Jr EH, Bonifas JM. Recessive X-linked ichthyosis: lack of immunologically detectable steroid sulfatase enzyme protein. Hum Genet 1985; 71 (3): 201–205PubMedCrossRef Epstein Jr EH, Bonifas JM. Recessive X-linked ichthyosis: lack of immunologically detectable steroid sulfatase enzyme protein. Hum Genet 1985; 71 (3): 201–205PubMedCrossRef
73.
go back to reference Epstein Jr EH, Krauss RM, Shackleton CH. X-linked ichthyosis: increased blood cholesterol sulfate and electrophoretic mobility of low-density lipoprotein. Science 1981; 214 (4521): 659–660PubMedCrossRef Epstein Jr EH, Krauss RM, Shackleton CH. X-linked ichthyosis: increased blood cholesterol sulfate and electrophoretic mobility of low-density lipoprotein. Science 1981; 214 (4521): 659–660PubMedCrossRef
74.
go back to reference Chipev CC, Yang JM, DiGiovanna JJ, et al. Preferential sites in keratin 10 that are mutated in epidermolytic hyperkeratosis. Am J Hum Genet 1994; 54 (2): 179–190PubMed Chipev CC, Yang JM, DiGiovanna JJ, et al. Preferential sites in keratin 10 that are mutated in epidermolytic hyperkeratosis. Am J Hum Genet 1994; 54 (2): 179–190PubMed
75.
go back to reference Bale SJ, DiGiovanna JJ. Genetic approaches to understanding the keratinopathies. Adv Dermatol 1997; 12: 99–114PubMed Bale SJ, DiGiovanna JJ. Genetic approaches to understanding the keratinopathies. Adv Dermatol 1997; 12: 99–114PubMed
76.
go back to reference GeneTests GeneClinics. Laboratory directory [online]. Available from URL: www.genetests.org [Accessed 2002 Dec 6] GeneTests GeneClinics. Laboratory directory [online]. Available from URL: www.genetests.org [Accessed 2002 Dec 6]
77.
go back to reference Frost P, Van Scott EJ. Ichthyosiform dermatoses: classification based on anatomic and biometric observations. Arch Dermatol 1966; 94 (2): 113–126PubMedCrossRef Frost P, Van Scott EJ. Ichthyosiform dermatoses: classification based on anatomic and biometric observations. Arch Dermatol 1966; 94 (2): 113–126PubMedCrossRef
78.
go back to reference Ishida-Yamamoto A, McGrath JA, Judge MR, et al. Selective involvement of keratins K1 and K10 in the cytoskeletal abnormality of epidermolytic hyperkeratosis (bullous congenital ichthyosiform erythroderma). J Invest Dermatol 1992; 99 (1): 19–26PubMedCrossRef Ishida-Yamamoto A, McGrath JA, Judge MR, et al. Selective involvement of keratins K1 and K10 in the cytoskeletal abnormality of epidermolytic hyperkeratosis (bullous congenital ichthyosiform erythroderma). J Invest Dermatol 1992; 99 (1): 19–26PubMedCrossRef
79.
go back to reference Robinson-Bostom L, McDonald CJ. Ichthyosis. In: McDonald CJ, editor. Immunomodulatory and cytotoxic agents in dermatology. New York: Marcel Deckker, 1997: 293–300 Robinson-Bostom L, McDonald CJ. Ichthyosis. In: McDonald CJ, editor. Immunomodulatory and cytotoxic agents in dermatology. New York: Marcel Deckker, 1997: 293–300
80.
go back to reference Allen A, Siegfried E, Silverman R, et al. Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. Arch Dermatol 2001; 137 (6): 747–750PubMed Allen A, Siegfried E, Silverman R, et al. Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. Arch Dermatol 2001; 137 (6): 747–750PubMed
81.
go back to reference Gibberd FB, Billimoria JD, Page NG, et al. Heredopathia atactica polyneuritiformis (Refsum’s disease) treated by diet and plasma-exchange. Lancet 1979; I (8116): 575–578CrossRef Gibberd FB, Billimoria JD, Page NG, et al. Heredopathia atactica polyneuritiformis (Refsum’s disease) treated by diet and plasma-exchange. Lancet 1979; I (8116): 575–578CrossRef
82.
go back to reference Moser HW, Braine H, Pyeritz RE, et al. Therapeutic trial of plasmapheresis in Refsum disease and in Fabry disease. Birth Defects Orig Artic Ser 1980; 16 (1): 491–497PubMed Moser HW, Braine H, Pyeritz RE, et al. Therapeutic trial of plasmapheresis in Refsum disease and in Fabry disease. Birth Defects Orig Artic Ser 1980; 16 (1): 491–497PubMed
83.
go back to reference Goldsmith LA, Baden HP. Propylene glycol with occlusion for treatment of ichthyosis. JAMA 1972; 220 (4): 579–580PubMedCrossRef Goldsmith LA, Baden HP. Propylene glycol with occlusion for treatment of ichthyosis. JAMA 1972; 220 (4): 579–580PubMedCrossRef
84.
go back to reference Germann R, Schindera I, Kuch M, et al. Life threatening salicylate poisoning caused by percutaneous absorption in severe ichthyosis vulgaris [in German]. Hautarzt 1996; 47 (8): 624–627PubMedCrossRef Germann R, Schindera I, Kuch M, et al. Life threatening salicylate poisoning caused by percutaneous absorption in severe ichthyosis vulgaris [in German]. Hautarzt 1996; 47 (8): 624–627PubMedCrossRef
85.
go back to reference Chiaretti A, Schembri Wismayer D, Tortorolo L, et al. Salicylate intoxication using a skin ointment. Acta Paediatr 1997; 86 (3): 330–331PubMedCrossRef Chiaretti A, Schembri Wismayer D, Tortorolo L, et al. Salicylate intoxication using a skin ointment. Acta Paediatr 1997; 86 (3): 330–331PubMedCrossRef
86.
go back to reference Redondo P, Bauza A. Topical N-acetylcysteine for lamellar ichthyosis [letter]. Lancet 1999; 354 (9193): 1880PubMedCrossRef Redondo P, Bauza A. Topical N-acetylcysteine for lamellar ichthyosis [letter]. Lancet 1999; 354 (9193): 1880PubMedCrossRef
87.
go back to reference Kragballe K, Steijlen PM, Ibsen HH, et al. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization: results of a randomized, double-blind, vehicle-controlled, right/left comparative study. Arch Dermatol 1995; 131 (5): 556–560PubMedCrossRef Kragballe K, Steijlen PM, Ibsen HH, et al. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization: results of a randomized, double-blind, vehicle-controlled, right/left comparative study. Arch Dermatol 1995; 131 (5): 556–560PubMedCrossRef
88.
go back to reference Lucker GP, van de Kerkhof PC, van Dijk MR, et al. Effect of topical calcipotriol on congenital ichthyoses. Br J Dermatol 1994; 131 (4): 546–550PubMedCrossRef Lucker GP, van de Kerkhof PC, van Dijk MR, et al. Effect of topical calcipotriol on congenital ichthyoses. Br J Dermatol 1994; 131 (4): 546–550PubMedCrossRef
89.
go back to reference Lucker GP, van de Kerkhof PC, Cruysberg JR, et al. Topical treatment of Sjogren-Larsson syndrome with calcipotriol. Dermatology 1995; 190 (4): 292–294PubMedCrossRef Lucker GP, van de Kerkhof PC, Cruysberg JR, et al. Topical treatment of Sjogren-Larsson syndrome with calcipotriol. Dermatology 1995; 190 (4): 292–294PubMedCrossRef
90.
go back to reference Steijlen PM, Reifenschweiler DO, Ramaekers FC, et al. Topical treatment of ichthyoses and Darier’s disease with 13-cis- retinoic acid: a clinical and immunohistochemical study. Arch Dermatol Res 1993; 285 (4): 221–226PubMedCrossRef Steijlen PM, Reifenschweiler DO, Ramaekers FC, et al. Topical treatment of ichthyoses and Darier’s disease with 13-cis- retinoic acid: a clinical and immunohistochemical study. Arch Dermatol Res 1993; 285 (4): 221–226PubMedCrossRef
91.
go back to reference Hofmann B, Stege H, Ruzicka T, et al. Effect of topical tazarotene in the treatment of congenital ichthyoses. Br J Dermatol 1999; 141 (4): 642–646PubMedCrossRef Hofmann B, Stege H, Ruzicka T, et al. Effect of topical tazarotene in the treatment of congenital ichthyoses. Br J Dermatol 1999; 141 (4): 642–646PubMedCrossRef
92.
go back to reference Jensen TG, Jensen UB, Jensen PK, et al. Correction of steroid sulfatase deficiency by gene transfer into basal cells of tissue-cultured epidermis from patients with recessive X-linked ichthyosis. Exp Cell Res 1993; 209 (2): 392–397PubMedCrossRef Jensen TG, Jensen UB, Jensen PK, et al. Correction of steroid sulfatase deficiency by gene transfer into basal cells of tissue-cultured epidermis from patients with recessive X-linked ichthyosis. Exp Cell Res 1993; 209 (2): 392–397PubMedCrossRef
93.
go back to reference Choate KA, Medalie DA, Morgan JR, et al. Corrective gene transfer in the human skin disorder lamellar ichthyosis. Nat Med 1996; 2 (11): 1263–1267PubMedCrossRef Choate KA, Medalie DA, Morgan JR, et al. Corrective gene transfer in the human skin disorder lamellar ichthyosis. Nat Med 1996; 2 (11): 1263–1267PubMedCrossRef
94.
go back to reference Peck GL, DiGiovanna JJ. The retinoids. In: Freedberg IM, Eisen AZ, Wolff K, et al., editors. Fitzpatrick’s dermatology in general medicine. New York: McGraw-Hill, 1999: 2810–2820 Peck GL, DiGiovanna JJ. The retinoids. In: Freedberg IM, Eisen AZ, Wolff K, et al., editors. Fitzpatrick’s dermatology in general medicine. New York: McGraw-Hill, 1999: 2810–2820
95.
go back to reference DiGiovanna JJ, Peck GL. Oral synthetic retinoid treatment in children. Pediatr Dermatol 1983; 1 (1): 77–88PubMedCrossRef DiGiovanna JJ, Peck GL. Oral synthetic retinoid treatment in children. Pediatr Dermatol 1983; 1 (1): 77–88PubMedCrossRef
96.
go back to reference Virtanen M, Gedde-Dahl Jr T, Mork NJ, et al. Phenotypic/genotypic correlations in patients with epidermolytic hyperkeratosis and the effects of retinoid therapy on keratin expression. Acta Derm Venereol 2001; 81 (3): 163–170PubMedCrossRef Virtanen M, Gedde-Dahl Jr T, Mork NJ, et al. Phenotypic/genotypic correlations in patients with epidermolytic hyperkeratosis and the effects of retinoid therapy on keratin expression. Acta Derm Venereol 2001; 81 (3): 163–170PubMedCrossRef
97.
go back to reference Soriatane package insert. Nutley (NJ): Roche Laboratories Inc., 2001 Jan Soriatane package insert. Nutley (NJ): Roche Laboratories Inc., 2001 Jan
98.
go back to reference Isotretinoin package insert. Nutley (NJ): Roche Laboratories Inc., 2002 Jun Isotretinoin package insert. Nutley (NJ): Roche Laboratories Inc., 2002 Jun
99.
100.
go back to reference Lucker GP, Heremans AM, Boegheim PJ, et al. Oral treatment of ichthyosis by the cytochrome P-450 inhibitor liarozole. Br J Dermatol 1997; 136 (1): 71–75PubMedCrossRef Lucker GP, Heremans AM, Boegheim PJ, et al. Oral treatment of ichthyosis by the cytochrome P-450 inhibitor liarozole. Br J Dermatol 1997; 136 (1): 71–75PubMedCrossRef
Metadata
Title
Ichthyosis
Etiology, Diagnosis, and Management
Authors
Dr John J. DiGiovanna
Leslie Robinson-Bostom
Publication date
01-02-2003
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 2/2003
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200304020-00002

Other articles of this Issue 2/2003

American Journal of Clinical Dermatology 2/2003 Go to the issue

Review Article

Darier’s Disease